2m 2m 2m 2m 2m 2m 2m
Lexicon Pharma (LXRX)
NASDAQ
$2.16-$0.005 (-0.23%)
Price as of Jun 23, 2026 7:49 PM EDT- $955.0MMarket Cap
- 192.88%1-Year Change
- BiotechnologyIndustry
Lexicon Pharma (LXRX)
$2.16-$0.005 (-0.23%)
LXRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.16 | ||
Change | +$0.14 (+6.97%) | ||
Open | $2.10 | ||
High | $2.23 | ||
Low | $2.06 | ||
Previous Close | $2.15 | ||
Volume | 2,774,239 | ||
30-Day Average Volume | 2,223,230 | ||
1-Week Change | 9.69% | ||
1-Month Change | -0.46% | ||
1-Year Change | 192.88% | ||
3-Year Change | -7.33% | ||
5-Year Change | -54.06% | ||
Fundamentals | |||
Shares Outstanding | 444.2M | ||
Total Assets | $268.8M | ||
Market Cap | $955.0M | ||
Enterprise Value | $966.6M | ||
Period: QTR TTM FY | |||
Revenue | $21.1M | ||
Net Income | -$1.0M | ||
Free Cash Flow | -$14.7M | ||
EBIT | -$1.0M | ||
EBITDA | -$933,000.00 | ||
Net Working Capital | $176.1M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -1,036 | ||
Enterprise Value/Revenue | 46 | ||
P/B | 5 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -65 | ||
Price/Operating Cash Flow | -65 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 05/21/2015 | ||
Earnings & Revenue